Related by context. All words. (Click for frequent words.) 70 pmol L 70 mIU ml 69 pg mL 67 μmol L 67 mL/min/#.# m2 67 mL/min/#.# m 2 67 μg mL 66 pg ml 66 ng dL 66 nM 66 microg 66 mcg mL 65 ug kg 65 ug ml 65 ertapenem 65 μg ml 65 mEq L 65 IU ml 65 mg kg dose 65 aspartate aminotransferase 65 μg kg 64 seroprotection 64 μg L 64 mg/m2/day 64 alanine aminotransferase 64 mg TID 64 anti HBs 63 leukocyte count 63 baseline Hb 63 Engerix B 63 g dl 63 % Confidence Interval 63 atazanavir ritonavir 63 rFSH 63 fosamprenavir 63 dexamethasone Decadron 63 mg QD 63 euthyroid 63 mIU L 63 ug mL 63 serum concentrations 63 μg d 63 log# copies mL 63 ng ml 63 nmol 63 mU L 63 aspartate aminotransferase AST 62 hemagglutination inhibition 62 mcg dose 62 ritonavir boosted atazanavir 62 μg liter 62 alanine aminotransferase ALT 62 rizatriptan 62 mU liter 62 Cmax 62 antibody titer 62 statin monotherapy 62 Peg IFN 62 PSA nadir 62 nmol liter 62 ng dl 62 lopinavir r 62 efavirenz EFV 62 undetectable HBV DNA 62 MIC# [001] 62 neutrophil counts 62 mmol l 61 piperacillin tazobactam 61 μg dose 61 #mmHg [001] 61 mg m² 61 log# reduction 61 achieved PASI 61 μg dL 61 abacavir lamivudine 61 -#.# mg dL [002] 61 fumarate 61 uM 61 mm Hg systolic 61 REYATAZ r arm 61 MBq 61 IFN α 61 mcg QD 61 concentration Cmax 61 HBeAg seroconversion 61 GHRH 61 nmol L 61 pmol liter 61 #.#mg/kg [002] 61 evaluable subjects 61 mcg kg 61 #ng/ml 61 achieved ACR# 61 hours postdose 61 NOAEL 61 HCV replicon 61 antibody titers 61 micromoles 61 cells μL 61 mmHg diastolic 61 cells mcL 61 umol L 61 daily subcutaneous injections 61 lymphocyte count 61 relapsed MM 61 #mg doses [002] 61 serum phosphorus 61 seropositivity 60 diuretic chlorthalidone 60 mcg albinterferon alfa 2b 60 PASI scores 60 mg BID 60 underwent surgical resection 60 serum HBV DNA 60 nicardipine 60 fluticasone furoate 60 Pharmacokinetic parameters 60 serum creatinine levels 60 mg dose 60 certolizumab 60 Mg Uk 60 ng mL 60 PEG IFN 60 mg kg bw 60 #.#mg/dL 60 DAS# remission 60 serum cortisol 60 pT3 60 mg/m2 dose 60 LPV r 60 mCi 60 nmol L. 60 mmol liter 60 iPTH 60 fluticasone salmeterol 60 intravenous bolus 60 creatinine ratio 60 SGPT 60 oral prednisone 60 mg d 60 complete cytogenetic response 60 ritonavir boosted 60 chlorambucil 60 SCIg 60 #mg/kg [001] 60 mL kg 60 albumin excretion 60 interquartile range 60 #OHD 60 ALT elevation 60 mg Androxal 60 μg dl 60 #μg [001] 59 tolterodine ER 59 micrograms mL 59 HBeAg negative patients 59 #mg BID [003] 59 serum albumin 59 isoprostane 59 seronegative 59 hemoglobin Hb 59 sUA 59 administered subcutaneously 59 fluvastatin 59 undetectable viral 59 amprenavir 59 urine albumin 59 anemia hemoglobin 59 microgram kg 59 hsCRP levels 59 LEXIVA r 59 pmol 59 epoetin alpha 59 #mg/m# [001] 59 CIN2 + 59 lamivudine refractory patients 59 mmol 59 tinzaparin 59 indinavir 59 plasma HCV RNA 59 mg eq 59 peginterferon alfa 2a 59 mm Hg diastolic 59 micrograms ml 59 atorvastatin #mg 59 tipranavir r 59 timepoints 59 Hb A1C 59 saline placebo 59 #mg/day [002] 59 lactate dehydrogenase 59 oral allopurinol 59 hemoglobin concentration 59 baseline HbA1c 59 mmHg systolic 59 #ug [002] 59 mcL 59 flutamide 59 lactate dehydrogenase LDH 59 ritonavir boosted lopinavir 59 #ug [001] 59 biochemical relapse 59 NovoLog ® Mix 59 elevated transaminases 59 MMSE score 59 cGy 59 quetiapine risperidone 59 low dose Iluvien 59 mg RDEA# 59 % CI #.#-#.# [003] 59 #mg/kg [002] 59 fasting plasma glucose FPG 59 ethambutol 59 transaminase elevations 59 mg dl 59 BARACLUDE ® 59 mcg ml 59 mcg BID 59 mm3 59 IOP lowering 58 g dL 58 QTcF 58 normal ULN 58 IU mL 58 posaconazole 58 delivered subcutaneously 58 salmeterol fluticasone propionate 58 epoetin beta 58 lispro 58 ALT flares 58 CCyR 58 serum LDL cholesterol 58 intravesical therapy 58 CsA 58 8mg/kg 58 TPV r 58 pegylated interferon alfa 2a 58 boosted atazanavir 58 plasma folate 58 eosinophil count 58 intramuscularly 58 follitropin beta 58 #mg QD [002] 58 gm dl 58 sitosterol 58 PaO 2 58 μg 58 PREZISTA ritonavir 58 #.#/#.# mmHg [001] 58 log# 58 norethindrone 58 Biaxin clarithromycin 58 serum potassium 58 ml min 58 methacholine challenge 58 elevated ALT 58 mcg kg min 58 6mg 58 CRp 58 mmol L 58 #mg dose [002] 58 milliliters mL 58 oxycodone CR 58 ARCOXIA 58 ml kg 58 #mg/day [001] 58 SGOT 58 serum lipid levels 58 epoetin alfa 58 mcg Albuferon 58 NNT = 58 comparator arm 58 titrated glipizide 58 salmeterol fluticasone 58 Mg Usa 58 PREZISTA r arm 58 HBV DNA levels 58 antiandrogen 58 fluticasone propionate FP 58 mmol L. 58 dose melphalan 58 pimecrolimus cream 58 MCyR 58 mCi m 2 58 poor metabolizers 58 subcutaneously injected 58 nadolol 58 mg qd 58 Serum creatinine 58 titers 58 mcg linaclotide 58 CK MB 58 serum phosphate levels 58 homozygotes 58 Platelet counts 58 HBV DNA 58 β blockers 58 isoproterenol 58 nondiabetic patients 58 reactogenicity 58 lumbar spine BMD 58 receiving INTRON 58 lymphocytosis 58 nanomolar 58 sensitivity specificity 58 #OHD levels 58 placebo PBO 58 octreotide LAR 58 timolol 58 glucuronide 58 dehydroepiandrosterone sulfate 58 NPH insulin 58 hemoglobin concentrations 58 statistical significance p 58 cefotaxime 58 #.#ng/ml 58 HI titers 58 mg/# h 58 μg l 58 serum urate 58 idraparinux 58 immunostaining 58 serum TSH 58 steroid dexamethasone 58 hMG 58 hypogonadal 58 x ULN 57 systemic hypotension 57 receiving VICTRELIS 57 ropivacaine 57 bioavailable testosterone 57 q#h 57 dosing cohort 57 binary restenosis 57 azilsartan medoxomil 57 -#.# log# copies mL 57 posttreatment 57 definite stent thrombosis 57 candesartan cilexetil 57 hepatorenal syndrome 57 tPSA 57 imiquimod cream 57 fractional shortening 57 mL sec 57 glomerular filtration rate 57 AUCs 57 receiving prophylactic anticoagulation 57 dalteparin 57 Pharmacokinetics PK 57 log# IU mL 57 detectable HCV RNA 57 mg kg Hematide 57 CrCl 57 treatment naïve genotype 57 ULORIC 57 4mg/kg 57 serum ALT 57 #.#mg/kg [001] 57 severe neutropenia 57 MAS XR 57 HGPIN 57 glomerular filtration 57 mg/# hours 57 kilogram mg kg 57 serum HCV RNA 57 mg q#h 57 darunavir r 57 postintervention 57 imipenem 57 Decitabine 57 lopinavir r arm 57 oxcarbazepine 57 mcg kg REBETOL 57 μM 57 intact parathyroid hormone 57 pharmacologically active isomer 57 nelfinavir 57 inhibitory concentrations 57 mmol kg 57 antithymocyte globulin 57 MULTAQ 57 detemir 57 response CCyR 57 glycosylated hemoglobin HbA1c 57 genotypic resistance 57 -#.# ± [002] 57 dosed orally 57 ceftazidime 57 HBeAg 57 plasma cortisol 57 heterozygotes 57 mcg doses 57 ARB telmisartan 57 #μg [002] 57 XIENCE V PROMUS Stent 57 mCi kg 57 CANCIDAS 57 pyrazinamide 57 serum sodium concentration 57 Plasma concentrations 57 % CI #.#-#.# [007] 57 highest tertile 57 3mg/kg 57 nmol l 57 HbA 1c levels 57 #mg q8h 57 serum testosterone 57 AUC0 57 neutrophil count 57 serum urate levels 57 baseline LDH 57 #/#mg 57 corticosteroid dose 57 bolus injection 57 urinary iodine 57 + PH# 57 amoxicillin clavulanate 57 6 mercaptopurine 57 p = NS 57 Median PFS 57 tirofiban 57 simvastatin #mg 57 GnRH agonist 57 ALT elevations 57 golimumab CNTO 57 unfractionated heparin UFH 57 intravenous dosing 57 interferon alfa 2b 57 #mg/m# [002] 57 rapid virological response 57 seroprotective 57 rHuEPO 57 uL 57 HYZAAR 57 3mg 57 plus medroxyprogesterone acetate 57 beta2 agonist 57 PBMCs 57 KRAS mutations occur 57 normotensive 57 mg dosed twice 57 CR CRu 57 nadroparin 57 ketorolac 57 IgM 57 Epoetin Alfa 57 HBsAg 57 BENICAR HCT 57 AZT zidovudine Retrovir 57 urinary albumin excretion 57 insulin glulisine 57 #mg dose [003] 57 serum aminotransferase levels 57 placebo dexamethasone 57 HIV RNA 57 mg mL 57 mu g 57 mg tid 57 aminotransferase levels 57 serum IGF 57 mg ustekinumab 57 ribavirin RBV 57 prednisone prednisolone 57 #.#mmol L [002] 57 timepoint 57 HbA 1c 57 mEq 57 mg kg ip 57 apolipoprotein B 56 elevated LDH 56 TMC# r 56 thyroglobulin 56 oral antidiabetic medication 56 lymphocyte counts 56 biologic DMARD 56 infused intravenously 56 intramuscular dose 56 dosing cohorts 56 #.#mg [003] 56 MADRS score 56 EURIDIS 56 Hb levels 56 budesonide pMDI 56 cells uL 56 microgram mcg 56 IFN beta 56 Wistar rats 56 elevated creatinine 56 Flu Cy 56 HBeAg positive 56 micromolar 56 Hb A1c 56 transaminase levels 56 mg orally 56 injected subcutaneously 56 stent binary restenosis 56 median PFS 56 dexamethasone 56 pharmacokinetic PK profile 56 trimethoprim 56 endoscopic remission 56 mg BID dose 56 Navelbine 56 beclomethasone dipropionate 56 5 Fluorouracil 56 ìg 56 plasma pharmacokinetics 56 millimoles per 56 DAS# scores 56 â ‰ ¥ 56 EpCAM expression 56 milligram mg 56 mg dL 56 darbepoetin alfa 56 #.#g/day 56 mean baseline HbA1c 56 adjunctive placebo 56 serum antibody 56 terfenadine 56 hypophosphatemia 56 seroconversion 56 dose cohort 56 cTnI 56 specific antigen PSA 56 copies ml 56 P = .# 56 per deciliter mg 56 emtricitabine tenofovir 56 mg p = 56 transaminases 56 serum calcium levels 56 malignancy HCM 56 iodixanol 56 lumbar spine bone 56 F FDG PET 56 TNFalpha 56 thyroid stimulating hormone 56 deferoxamine 56 nanograms per 56 caspofungin 56 Solid Tumors criteria 56 AST ALT 56 aminotransferase elevations greater 56 virologic failure 56 mol L 56 Am J Cardiol 56 Viread Emtriva 56 Peginterferon 56 OADs 56 GH deficiency 56 CK # plasma concentrations 56 nanomoles per 56 RNA copies mL 56 serum prostate 56 #.#/#.# mm Hg [003] 56 VELCADE melphalan 56 creatine kinase 56 gliclazide 56 #mg dose [001] 56 bFGF 56 tapentadol ER 56 μmol 56 HIV HCV coinfected 56 EDSS score 56 ergocalciferol 56 serum retinol 56 ascending doses 56 dose cohorts 56 LV ejection fraction 56 parasitemia 56 mm ³ 56 cEVR 56 mcg dL 56 insulin lispro 56 Hb 56 methylmalonic acid 56 progression TTP 56 inhibitory concentration 56 tryptase 56 ABC/3TC 56 complete cytogenetic 56 prior chemotherapy regimens 56 mg kg 56 Peginterferon Alfa 2a 56 μSv 56 imatinib therapy 56 ribavirin USP 56 systemic corticosteroids 56 transdermal estradiol 56 danazol 56 hypokalemia 56 Q2W 56 undetectable HCV RNA 56 doxorubicin cyclophosphamide 56 PegIFN 56 intratympanic 56 triglyceride concentrations 56 Hgb 56 medroxyprogesterone acetate 56 ATACAND 56 lopinavir 56 PREZISTA r 56 mM 56 acetazolamide 56 micrograms mcg 56 subcutaneous dose 56 glulisine 56 liver histology 56 Acetate Rectal Suppositories 56 pCR 56 seroconverted 56 hydroxyvitamin D levels 56 endogenous EPO 56 pharmacokinetic parameters 56 tHcy 56 tazobactam 56 cefazolin 56 hematological parameters 56 Sanofi Pasteur Fluzone 56 achieved CCyR 56 moderate renal impairment 56 aldosterone antagonist 56 plus prednisone 56 serum calcium 56 peginterferon alfa 2a #KD 56 APTIVUS r 56 weekly subcutaneous injections 56 plasma concentrations 56 antiretroviral naive 56 microvessel density 56 SCr 56 μmol l 56 PRADAXA #mg 56 plasma concentration Cmax 56 IgG 56 calculated creatinine clearance 56 μL 56 ddI 56 ALT normalization 56 6MWD 55 posttransplant 55 Tipranavir 55 thyroid stimulating hormone TSH 55 exhaled NO 55 prucalopride 55 infliximab monotherapy 55 gastric pH 55 CHOP chemotherapy 55 Kidney Int 55 neostigmine 55 generalized edema 55 Creatinine 55 iniparib BSI 55 aminotransferases 55 creatinine levels 55 min -1 55 pg g 55 TEAEs 55 #mg BID [002] 55 hepatitis B immunoglobulin 55 serum phosphate 55 virologically 55 adefovir treated 55 viral titer 55 #mg #mg #mg [003] 55 interferon alfa 2a 55 NHANES III 55 oral prednisolone 55 #Gy 55 #.#-#.# [011] 55 dapagliflozin plus 55 gonadotropin 55 virologic failures 55 ceftriaxone 55 DLTs 55 hepatic enzymes 55 NRTI resistance 55 parous women 55 anagrelide 55 Myelosuppression 55 glycated hemoglobin 55 OGTT 55 #mg BID [001] 55 Moli# 55 subcutaneously administered 55 fraction LVEF 55 PegIFN RBV 55 ascending dose 55 EGFR TKI 55 ECOG PS 55 serum ferritin 55 HER2 expression 55 interleukin IL -6 55 plasma creatinine 55 hemoglobin A1c HbA1c 55 vitamin D2 55 CC genotype 55 HOMA IR 55 onset diabetes mellitus 55 rhEPO 55 mm Hg 55 urinary N telopeptide 55 transdermal fentanyl 55 continuous intravenous infusion 55 QT QTc 55 mg Proellex 55 HbA1C levels 55 bolus dose 55 ganciclovir 55 FluCAM arm 55 microgram doses 55 troponin T 55 HCV RESPOND 2 55 kg -1 55 daunorubicin 55 mg ml 55 plasma uric acid 55 Apidra ® 55 pegylated interferon alfa 55 plus dexamethasone 55 resected pancreatic cancer 55 dopamine partial agonist 55 creatinine clearance 55 n = 55 q8h 55 #mg/dL [002] 55 mg XP# 55 peginterferon alfa 2b 55 deep venous thromboses 55 pegIFN 55 gemcitabine cisplatin 55 9mg 55 racemic albuterol 55 F FDG 55 desvenlafaxine succinate 55 HbA1c levels 55 pT2 55 peripheral blood mononuclear 55 mycophenolate mofetil 55 UGT#A# * 55 antigen PSA levels 55 SUVmax 55 NNRTI resistance 55 plus prednisone prednisolone 55 severe renal impairment 55 viraemia 55 FOLFOX4 55 aged ≥ 55 CIMZIA ™ 55 intracranial hemorrhage ICH 55 bortezomib refractory 55 plasma renin 55 otamixaban 55 colorectal adenoma 55 micrograms μg 55 serum uric acid 55 maximal doses 55 oral diclofenac 55 Fasting blood glucose 55 dosage regimens 55 hemodynamically significant 55 FOLFIRI alone 55 serum IgE 55 mg/m2 55 weekly intravenous infusions 55 p = #.# [003] 55 ACTH 55 HBeAg positive patients 55 #.#mL 55 thyrotropin levels 55 cis retinoic acid 55 R tenofovir disoproxil 55 HBeAg + 55 hyperphenylalaninemia HPA due 55 statistically significant p = 55 pegylated interferon alpha 55 IgG antibody 55 inhaled fluticasone 55 CR nPR 55 divalproex sodium 55 HCV antibody 55 postmenopausal osteoporotic women 55 administered intramuscularly 55 eplerenone 55 Hemoglobin A1c HbA1c 55 PegIntron 55 angiographic restenosis 55 nitroprusside 55 benazepril 55 peginterferon alpha 2a 55 paraprotein 55 azathioprine 55 adjunctive ABILIFY 55 adefovir 55 FDG uptake 55 HbA1C 55 Hycamtin ® 55 LEXIVA 55 IEQ kg 55 mg kg hr 55 noninferiority 55 Response Evaluation Criteria 55 mRCC 55 TURBT 55 procalcitonin 55 irbesartan 55 mg administered orally 55 telaprevir dosed 55 calcipotriol 55 docetaxel chemotherapy 55 CIMZIA TM 55 BENICAR 55 lowest tertile 55 KRAS mutant tumors 55 postdose 55 maximally tolerated dose 55 ug L 55 dose dexamethasone 55 achieved mucosal healing 55 palifermin 55 -#.# log# 55 pretreatment baseline 55 specific IgE 55 HCV genotype 55 Insulin sensitivity 55 g mL 55 titer 55 intravesical 55 glycated hemoglobin levels 55 tacrolimus ointment 55 acellular pertussis vaccine 55 patients undergoing CABG 55 gemcitabine carboplatin 55 advanced adenoma 55 mitoxantrone plus 55 serum homocysteine 55 BUPHENYL 55 serum folate 55 plasma leptin 55 Forodesine HCl 55 microlitre 55 histologic subtype 55 Doxil ® 55 sustained virological response 55 CLL SLL 55 antiandrogens 55 5mg/kg 55 Omacetaxine mepesuccinate 55 Soriatane R 55 CDAI score 55 active comparator 55 microbiological eradication 55 creatine phosphokinase 55 trastuzumab Herceptin ® 55 1mg 55 arterial thromboembolic events 55 Pegasys peginterferon alfa 2a 55 atazanavir 55 metformin monotherapy 55 CIN3 + 55 mU 55 ejection fractions 55 plus methotrexate 55 #-#,# mg 55 cfu 54 ug g 54 myelodysplastic myeloproliferative diseases 54 amphotericin B 54 ciclesonide 54 5-FU/LV 54 macroalbuminuria 54 TYGACIL 54 rhGH 54 iobenguane 54 milliliter ng mL 54 peg IFN 54 Known hypersensitivity 54 zonisamide SR 54 #mg ATC 54 recurrent VTE 54 inhibitor RG# 54 neurologic progression 54 1mg 2mg 54 alfa 2a 54 stage IIIb IV 54 maximal dose 54 inotropic 54 mRNA expression 54 COZAAR 54 pCi l 54 low dose ritonavir 54 glargine 54 adalimumab 54 adalimumab Humira 54 REYATAZ ® 54 hip BMD 54 refractory NSCLC 54 Crohn Disease Activity 54 serum potassium levels 54 dobutamine 54 Capecitabine 54 Pegylated Interferon 54 mg/# mL [002] 54 mg simvastatin 54 Stent p = 54 intravenous bolus injection 54 serum estradiol 54 rt PA 54 nanomoles 54 CLINICAL STUDIES 54 mmHg 54 Target Lesion Revascularization TLR 54 d dimer 54 antibody titres 54 #mg/dL [001] 54 oral ribavirin 54 ATV RTV 54 confidence interval CI 54 preintervention 54 BUPHENYL R sodium phenylbutyrate 54 FTE staffing 54 dose cytarabine 54 clinically meaningful improvements 54 hepatitis C genotype 54 unresectable HCC 54 intraperitoneally 54 plus ribavirin 54 olmesartan 54 endometrial thickness 54 tipranavir ritonavir 54 hepatoma 54 virological failure 54 undergone splenectomy 54 TT genotype 54 creatine kinase MB 54 baseline FEV 54 INVEGA ® 54 dose dabigatran 54 acromegalic patients 54 serum sodium 54 LAB GHRH 54 peak plasma concentrations 54 ® emtricitabine 54 ribavirin Copegus 54 μl 54 low dose cytarabine 54 ribavirin therapy 54 diabetic rats 54 CLA supplementation 54 pooled comparator 54 NIHSS 54 TAXUS Express Stent 54 serum phosphorus levels 54 microliter 54 angiotensin converting enzyme inhibitor 54 viral titers 54 hemodialysis patients 54 3TC lamivudine Epivir 54 plasma glucose 54 #.#mg [004] 54 cobalamin 54 doxazosin 54 baseline serum creatinine 54 A1c levels 54 combination REBETOL PEG 54 pegylated alpha interferon 54 lanreotide 54 X ULN 54 Ramipril 54 paricalcitol 54 dosing intervals 54 chlorthalidone 54 seropositive patients 54 hematologic toxicity 54 parasitaemia 54 Ondansetron Injection USP 54 rifabutin 54 adiponectin concentrations 54 Losartan Potassium 54 virologic breakthrough 54 advanced adenomas 54 decitabine 54 leukocytosis 54 High Dose quadruples 54 PSADT 54 nonnucleoside reverse transcriptase inhibitors 54 adriamycin 54 intravenously administered 54 postop 54 tacrolimus 54 hematologic parameters 54 tibolone 54 activated partial thromboplastin 54 vincristine doxorubicin 54 IM progesterone 54 cefuroxime 54 pentoxifylline 54 histologically confirmed 54 valacyclovir